Top

Published in:

01-12-2013 | Migraine (R Cowan, Section Editor)

Does Exercise Make Migraines Worse and Tension Type Headaches Better?

Authors: Nada Ahmad Hindiyeh, John Claude Krusz, Robert Paul Cowan

Published in: Current Pain and Headache Reports | Issue 12/2013

Abstract

Many non-pharmacological treatments have been implicated in the treatment of primary headache, with exercise being a common recommendation. In this review we first provide an overview of the relationship between exercise and primary headaches. We then review the physiology of pain modulation, with focus on the endogenous opioids, endocannabinoids, and neuropeptides calcitonin gene-related peptide (CGRP) and brain-derived neurotrophic factor (BDNF), and their associations with primary headache and exercise. Finally, we summarize current literature evaluating effects of exercise on primary headache in an effort to understand the benefits and disadvantages of exercise in primary headaches.

Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA. The headaches. 3rd ed. Philadelphia: Lippincott, Williams and Wilkins; 2006.

Kojić Z, Stojanović D. Pathophysiology of migraine–from molecular to personalized medicine. Med Pregl. 2013;66:53–7.PubMedCrossRef

Halker RB, Vargas BB. Primary Exertional Headache: updates in the literature. Curr Pain Headache Rep. 2013;17:33.CrossRef

Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd ed. Cephalalgia. 2004;24:1–160.

Chen SP, Fuh JL, Lu SR, Wang SJ. Exertional headache—a survey of 1963 adolescents. Cephalalgia. 2009;29:401–7.PubMedCrossRef

Massey EW. Effort headache in runners. Headache. 1982;22:99–100.PubMedCrossRef

Thompson J. Exercise-induced migraine prodrome symptoms. Headache. 1987;27:250–1.PubMedCrossRef

Ross W, Lambert Jr MD, Deborah L, Burnet BA. Prevention of exercise-induced migraine by quantitative warm-up. Headache. 1985;25:317–9.

Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27:394–402.PubMedCrossRef

10.

Darling M. The use of exercise as a method of aborting migraine. Headache. 1991;31:616–8.PubMedCrossRef

11.

Atkinson R. Physical fitness and headache. Headache. 1977;17:189–91.PubMedCrossRef

12.

Söderberg E, Carlsson J, Stener-Victorin E. Chronic tension-type headache treated with acupuncture, physical training and relaxation training. Between-group differences. Cephalalgia. 2006;26:1320–9.PubMedCrossRef

13.

Andersen LL, Mortensen OS, Zebis MK, Jensen RH, Poulsen OM. Effect of brief daily exercise room headache among adults — with a secondary analysis of a randomized controlled trial. Scand J Work Environ Health. 2011;37:547–50.

14.

Mongini F, Evangelista A, Milani C, Ferrero L, Ciccone G, Ugolini A, et al. An educational and physical program to reduce headache, neck/shoulder pain in a working community: a cluster-randomized controlled trial. PLoS One. 2007;7.

15.

• Fricton V, Ouyang A, Look W. Does exercise therapy improve headache? A systematic review with meta-analysis. Curr Pain Headache Rep. 2009;13:413–9. A good review summarizing various studies looking at TTH and exercise. PubMedCrossRef

16.

Torelli P, Jensen R, Olesen J. Physiotherapy for tension-type headache: a controlled study. Cephalalgia. 2004;24:29–36.PubMedCrossRef

17.

Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation. 2003;107:3109–16.PubMedCrossRef

18.

Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation. 2001;104:1694–740.PubMedCrossRef

19.

Hughes J. Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res. 1975;88:295–308.PubMedCrossRef

20.

Pasternak GM, Goodman R, Snyder SH. An endogenous morphine-like factor in mammalian brain. Life Sci. 1975;16:1765–9.PubMedCrossRef

21.

Terenius L, Wahlström A. Morphine-like ligand for opiate receptors in human CSF. Life Sci. 1975;16:1759–64.CrossRef

22.

Hartwing AC. Peripheral beta-endorphin and pain modulation. Anesth Prog. 1991;38:75–8.

23.

Basbaum AI, Fields HL. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol. 1978;4:451–62.PubMedCrossRef

24.

Sicuteri F. Endorphins, opiate receptors and migraine headache. Headache. 1978;17:253–6.PubMedCrossRef

25.

Beamont A, Hughes J. Biology of opioid peptides. Ann Rev Pharmacol Toxicol. 1979;19:245–66.CrossRef

26.

Anselmi B, Baldi E, Casacci F, Salmon S. Endogenous opioids in cerebrospinal fluid and blood in idiopathic headache sufferers. Headache. 1980;20:294–9.PubMedCrossRef

27.

Genazzani AR, Nappi G, Facchinetti F, Micieli G, Petraglia F, Bono G, et al. Progressive impairment of CSF beta-EP levels in migraine sufferers. Pain. 1984;2:127–33.

28.

Misra UK, Kalita J, Triphathi GM, Bhoi SK. Is beta endorphin related to migraine headache and its relief? Cephalalgia. 2012;33:316–22.CrossRef

29.

Schwarz L, Kindermann W. Changes in beta-endorphin levels in response to aerobic and anaerobic exercise. Sports Med. 1992;13:25–36.PubMedCrossRef

30.

De Meirleir K, Naaktgeboren N, Vaan Steirteghen A, Gorus F, Olbrecht J, Block P. Beta-endorphin and ACTH levels in peripheral blood during and after aerobic and anaerobic exercise. Eur J Appl Physiol. 1986;55:5–8.CrossRef

31.

McMurray RG, Forsythe WA, Mar MH, Hardy CJ. Exercise intensity-related responses of beta-endorphin and catecholamines. Med Sci Sports Exer. 1987;19:570–4.

32.

Goldfarb AH, Hatfield BD, Armstrong D, Potts J. Plast beta-endorphin concentration: response to intensity and duration of exercise. Med Sci Sports Exer. 1990;22:241–4.

33.

Langenfeld ME, Hart LS, Kao PC. Plasma beta-endorphin responses to one-hour bicycling and running at 60% VO2max. Med Sci Sports Exer. 1987;19:83–6.

34.

Rahkila P, Halala E, Alen N, Salminen K, Laatikainen T. Beta-endorphin and corticotropin release is dependent on a threshold intensity of running in male endurance athletes. Life Sci. 1987;45:451–5.

35.

Brooks S, Burrin J, Cheetham ME, Hall GM, Yeo T, et al. The responses of the catecholaminese and beta-endorphin levels during extreme exercise. Eur J App Phsyiol. 1988;57:230–4.CrossRef

36.

Farrell PA, Kjaer M, Bach FW, Galbo H. Beta-endorphin and adrenocorticotropin response to supramaximal treadmill exercise in trained and untrained males. Acta Physiol Scand. 1987;130:619–25.PubMedCrossRef

37.

Rahkila P, Halala E, Salminen K, Laatikainen T. Responses of plasma endorphins to running exercises in male and female endurance athletes. Med Sci Sports Exer. 1987;19:451–5.

38.

Kraemer WJ, Patton JF, Knuttgen HG, Marchetelli LJ, Cruthirds C, et al. Hypothalamic-pituitary-adrenal responses to short-duration high-intensity cycle exercise. J App Physiol. 1989;66:161–6.CrossRef

39.

Schwarz L, Kindermann W. Beta-endorphin, adrenocorticotropic hormone, cortisol and catecholamines during aerobic and anaerobic exercise. Eur J App Phsyiol. 1990;61:165–71.CrossRef

40.

Schwarz L, Kindermann W. Beta-endorphin, catecholamines, and cortisol during exhaustive endurance exercise. Int J Sports Med. 1989;10:324–8.PubMedCrossRef

41.

Greco R, Gasperi V, Maccarrone M, Tassorelli C. The endocannabinoid system and migraine. Exp Neurol. 2010;224:85–91.PubMedCrossRef

42.

Dietrich A, McDaniel WF. Endocannabinoids and exercise. Br J Sports Med. 2004;38:536–41.PubMedCrossRef

43.

Sparling PB, Giurida A, Piomelli D, Rosskopf L, Dietrich A. Exercise activates the endocannabinoid system. Cognit Neurosci Neuropsychol. 2003;14:2209–11.

44.

Katona I, Freund TF. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med. 2008;14:923–30.PubMedCrossRef

45.

Wotherspoon G, Fox A, McIntyre P, Colley S, Bevan S, Winter J. Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. Neuroscience. 2005;135:235–45.PubMedCrossRef

46.

Anand U, Otto WR, Sanchez-Herrera D, Facer P, Yiangou Y, Korchev Y, et al. Cannabinoid receptor CB2 localization and agonist-mediated inhibition of capsaicin responses in human sensory neurons. Pain. 2008;138:667–80.PubMedCrossRef

47.

Russo EB. Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neur Endocrinol Lett. 2004;25:31–9.

48.

Vaughan CW, Connor M, Bagley EE, Christie MJ. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Mol Pharmacol. 2000;57:288–95.PubMed

49.

Akerman S, Kaube H, Goadsby PJ. Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. J Pharmacol Exp Ther. 2004;309:56–63.PubMedCrossRef

50.

Sarchielli P, Pini LA, Coppola F, Rossi C, Baldi A, Mancini ML, et al. Endocannabinoids in chronic migraine: CSF findings suggest a system failure. Neuropsychopharmacology. 2007;32:1384–90.PubMedCrossRef

51.

Van der Schueren BJ, Van Laere K, Gerard N, Bormans G, De Hoon JN. Interictal Type 1 cannabinoid receptor binding is increased in female migraine patients. Headache. 2012;52:433–40.PubMedCrossRef

52.

Perrotta A, Arce-Leal N, Tassorelli C, Gasperi V, Sances G, Blandini F, et al. Acute reduction of anandamide-hydrolase (FAAH) activity is coupled with a reduction of nociceptive pathways facilitation in medication-overuse headache subjects after withdrawal treatment. Headache. 2012;52:1350–61.PubMedCrossRef

53.

Petrosino S, Palazzo E, deNovellis V, et al. Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats. Neuropharmacology. 2007;52:415–22.PubMedCrossRef

54.

Akerman S, Holland PR, Goadsby PJ. Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons. J Pharmacol Exp Ther. 2007;320:64–71.PubMedCrossRef

55.

Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A. Exercise activates the endocannabinoid system. Neuro Report. 2003;14:2209–11.

56.

Raichlen DA, Foster AD, Gerdeman GL, Seillier A, Giuffrida A. Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals and the evolution of the runner’s high. J Exp Biol. 2012;215:1331–6.PubMedCrossRef

57.

Raichlen DA, Foster AD, Seillier A, Giuffrida A, Gerdeman GL. Exercise-induced endocannabinoid signaling is modulated by intensity. Eur J Appl Physiol. 2013;113:869–75.PubMedCrossRef

58.

• Bigal ME, Walter S, Rapoport AM. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development. Headache. 2013;53(8):1230–44. Good review on the role of CGRP in migraine and future theraputic options.

59.

Arulmani U, MaassenVanDenBrink A, Villalon CM, Saxena PR. Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur J Pharmacol. 2004;500:315–30.PubMedCrossRef

60.

Gallai V, Sarchielli P, Floridi A, Franceschini M, Codini M, Giloti G, et al. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia. 1995;15:384–90.PubMed

61.

Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28:183–7.PubMedCrossRef

62.

Ashina M, Bendetsen L, Jensen R, Schifter S, Olesen J. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside attacks. Pain. 2000;86:133–8.PubMedCrossRef

63.

Lassen LH, Jacobsen VB, Haderselv PA, Sperling B, Iversen HK, Olesen J, et al. Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients. J Headache Pain. 2008;9:151–7.PubMedCrossRef

64.

Lind H, Brudin L, Lindholm L, Edvinsson L. Different levels of sensory neuropeptides (calcitonin gene-related peptide and substance P) during and after exercise in man. Clin Physiol. 1996;16:73–82.PubMedCrossRef

65.

Schifter S, Breum L, Niclasen B, Vollmer-Larsen A, Rasmussen HS, Graif-Larsen O. Calcitonin gene-related peptide during exercise and training. Horm Metab Res. 1995;27:473–5.PubMedCrossRef

66.

Hasbak P, Lundby C, Olsen NV, Schifter S, Kanstrup IL. Calcitonin gene-related peptide and adrenomedullin release in humans: effects of exercise and hypoxia. Regul Pept. 2002;108:89–95.PubMedCrossRef

67.

Jonhagen S, Achermann P, Saartok T, Renstron PA. Calcitonin gene-related peptide and neuropeptide Y in skeletal muscle after eccentric exercise: a microdialysis study. Br J Sports Med. 2006;40:264–7.PubMedCrossRef

68.

Thompson SW, Bennett DL, Kerr BJ, Bradbury EJ, McMahon SB. Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord. Proc Natl Acad Sci U S A. 1999;96:7714–8.PubMedCrossRef

69.

Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol. 2000;10:381–91.PubMedCrossRef

70.

Buldyrev I, Tanner NM, Hsieh HY, Dodd EG, Nguyen LT, Balkowiec A. Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons. J Neurochem. 2006;99:1338–50.PubMedCrossRef

71.

Balkowiec-Iskra E, Vermehren-Schmaedick A, Balkowiec A. Tumor necrosis factor-alpha increases brain-derived neurotrophic factor expression in trigeminal ganglion neurons in an activity-dependent manner. Neuroscience. 2011;180:322–33.PubMedCrossRef

72.

Blandini F, Rinaldi L, Tassorelli C, Sances G, Motta M, Samuele A, et al. Peripheral levels of BDNF and NGF in primary headaches. Cephalalgia. 2006;26:136–42.PubMedCrossRef

73.

Túlio M, Tanure A, Gomez RS, Hurtado RC, Teixeira AL, Domingues RB. Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study. J Headache Pain. 2010;11:427–30.CrossRef

74.

Fischer M, Wille G, Klien S, Shanib H, Holle D, Gaul C, et al. Brain-derived neurotrophic factor in primary headaches. J Headache Pain. 2012;13:469–75.PubMedCrossRef

75.

Sarchielli P, Mancini ML, Floridi A, Coppola F, Rossi C, Nardi K, et al. Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J Pain. 2007;8:737–45.PubMedCrossRef

76.

Nugraha B, Karst M, Engeli S, Gutenbrunner C. Brain-derived neurotrophic factor and exercise in fibromyalgia syndrome patients: a mini review. Rheumatol Int. 2012;32:2593–9.PubMedCrossRef

77.

Sarchielli P, DiFilippo M, Nardi K, Calabresi P. Sensitization, glutamate, and the link between migraine and fibromyalgia. Curr Pain Headache Rep. 2007;11:343–51.PubMedCrossRef

78.

Haas L, Portela LVC, Bohmer AE, Oses JP, Lara DR. Increased plasma levels of brain derived neurotrophic factor (BDNF) in patients with fibromyalgia. Neurochem Res. 2010;35:830–4.PubMedCrossRef

79.

Laske C, Stransky E, Eschweiler GW. Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants. J Psychiatr Res. 2007;41:600–5.PubMedCrossRef

80.

Duric V, McCarson KE. Neurokinin-1 (NK-1) receptor and brain-derived neurotrophic factor (BDNF) gene expression is differentially modulated in the rat spinal dorsal horn and hippo- campus during inflammatory pain. Mol Pain. 2007;3:32.PubMedCrossRef

81.

Xu HW, Li XC, Li HD, Ruan HZ, Liu ZZ. Effects of corticotrophin on pain behavior and BDNF, CRF levels in frontal cortex of rats suffering from chronic pain. Acta Pharmacol Sin. 2000;21:600–4.PubMed

82.

Knaepen K, Goekint M, Heyman EM, Meeusen R. Neuroplasticity-exercise-induced response of peripheral brain-derived neurotrophic factor. A systematic review of experimental studies in human subjects. Sports Med. 2010;40:765–801.PubMedCrossRef

83.

Neeper SA, Gomez-Pinilla F, Choi J, Cotman C. Exercise and brain neurotrophins. Nature. 1995;373:109.PubMedCrossRef

84.

Cotman CW, Berchtold NC. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci. 2002;25:295–301.PubMedCrossRef

85.

Liu YF, Chen HI, Yu L, Kuo YM, Wu FS, Chuang JI, et al. Upregulation of hippocampal TrkB and synaptotagmin is involved in treadmill exercise-enhanced aversive memory in mice. Neurobiol Learn Mem. 2008;90:81–9.PubMedCrossRef

86.

• Coelho FGM, Gobbi S, Andreatto CAA, Corazza DI, Pedroso RV, Santos-Galduroz RF. Physical exercise modulates peripheral levels of brain-derived neurotrophic factor (BDNF): a systematic review of experimental studies in the elderly. Arch Gerontol Geriat. 2013;56:10–5. Good review of BDNF and exercise, supporting moderate exercise to elevate BDNF levels in the elderly.CrossRef

87.

Huang T, Larsen KT, Ried-Larsen M, Moller NC, Andersen LB. The effects of physical activity and exercise on brain-derived neurotrophic factor in healthy humans: a review. Scand J Med Sci Sports. 2013;10.

88.

Schmidt-Kassow M, Schadle S, Otterbein S, Thiel C, Doehring A, Lotsch J, et al. Kinetics of serum brain-derived neurotrophic factor following low-intensity vs high- intensity exercise in men and women. Neuroreport. 2012;23:889–93.PubMedCrossRef

89.

Koseoglu E, Akboyraz A, Soyuer A, Ersoy AO. Aerobic exercise and plasma beta endorphin levels in patients with migrainous headache without aura. Cephalalgia. 2003;23:972–6.PubMedCrossRef

90.

Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia. 2002;22:54–61.PubMedCrossRef

91.

Cirulli F, Berry A, Alleva E. Intracerebroventricular administration of brain-derived neurotrophic factor in adult rats affects analgesia and spontaneous behavior but not memory retention in a Morris Water Maze task. Neurosci Lett. 2000;287:207–10.PubMedCrossRef

92.

Zhang X, Xu Y, Wang J, Zhou Q, Pu S, Jiang W, et al. The effect of intrathecal administration of glial activation inhibitors on dorsal horn BDNF overexpression and hind paw mechanical allodynia in spinal nerve ligated rats. J Neural Transm. 2012;119:329–36.PubMedCrossRef

93.

Ichikawa H, Yabuuchi T, Jin HW, Terayama R, Yamaai T, Deguchi T, et al. Brain-derived neurotrophic factor-immunoreactive primary sensory neurons in the rat trigeminal ganglion and trigeminal sensory nuclei. Brain Res. 2006;1081:113–8.PubMedCrossRef

94.

Locket DC, Campbell JF. The effects of aerobic exercise on migraine. Headache. 1992;32:50–4.CrossRef

95.

Dittrich SM, Günther V, Franz G, Burtscher M, Holzner B, Kopp M. Aerobic exercise with relaxation: influence of pain and psychological well-being in female migraine patients. J Sport Med. 2008;18:363–5.

96.

Domingues RB, Teixeira AL, Domingues SA. Physical practice is associated with less functional disability in medical students with migraine. Arq Neuropsiquiatr. 2011;69:39–43.PubMedCrossRef

97.

Baskin SM, Smitherman TA. Migraine and psychiatric disorders: comorbidities, mechanisms and clinical applications. Neurol Sci. 2009;30:61–5.CrossRef

98.

Carek PJ, Laibstain SE, Carek SM. Exercise for the treatment of depression and anxiety. Int J Psychiatry Med. 2011;41:15–28.PubMedCrossRef

99.

• Busch V, Gaul C. Exercise in migraine therapy- is there any evidence for efficacy? A critical review. Headache. 2008;48:890–9. Good review detailing several studies that have looked at the efficacy of exercise in migraine. PubMedCrossRef

100.

Narin SO, Pinar L, Erbas D, Ozturk V, Idiman F. The effects of exercise and exercise-related changes in blood nitric oxide level on migraine headache. Clin Rehabil. 2003;17:624–30.PubMedCrossRef

101.

Grimm L, Douglas D, Hanson P. Aerobic training in the prophylaxis of migraine. Med Sci Sports Exerc. 1981;13:98.CrossRef

102.

Gerber W, Miltner W, Gabler H, Hildebrand E, Larbig W. Bewegungs- und Sporttherapie bei chronischen Kopfschmerzen. In: Gerber W, Miltner W, Mayer K, editors. Vorgebnisse und Perspektiven interdisziplinärer Forschung. Weinheim: edition medizin. 1987:55–66.

103.

Varkey E, Cider A, Carlsson J, Linde M. Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls. Cephalalgia. 2011;31:1428–38.PubMedCrossRef

Title: Does Exercise Make Migraines Worse and Tension Type Headaches Better?
Authors: Nada Ahmad Hindiyeh
John Claude Krusz
Robert Paul Cowan
Publication date: 01-12-2013
Publisher: Springer US
Published in: Current Pain and Headache Reports / Issue 12/2013
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI: https://doi.org/10.1007/s11916-013-0380-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Does Exercise Make Migraines Worse and Tension Type Headaches Better?

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2013

Altitude Headache

Why Does Increased Exercise Decrease Migraine?

Headaches Related to Rheumatologic Disease

Ion Channels and Osteoarthritic Pain: Potential for Novel Analgesics

Chronic Daily Headache in the Elderly

Stem Cell Regeneration of Degenerated Intervertebral Discs: Current Status (Update)